Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pacific Strategic Financial Tbk (APIC) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Pacific Strategic Financial TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Pacific Strategic Financial Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Pacific Strategic Financial Tbk trades at Rp575 (market cap 6.59T, 834.1K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Pacific Strategic Financial Tbk is far larger — about 20.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Pacific Strategic Financial Tbk is more actively traded (834.1K versus 41.7K). Which is the better fit depends on your goals.

APICDGNS
Market Cap
6.59T316.25B
Volume
834.1K41.7K
Lot
8.34K417
Turnover
462.05M9.66M
Average Price
553.95231.65
Value
462.05M9.66M
Indicative Equilibrium Price
575230
Indicative Equilibrium Volume
7882.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

APIC
View details
DGNS
View details

About Pacific Strategic Financial Tbk

Founded in Jakarta on February 22nd 1989 as PT. Citramas Securindo. Name changed to be PT. Arta Pacific Securities on July 4th 2000. Conduct as broker dealer and underwriter in capital market.

Read more on APIC

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS